OB HOLDINGS BERHAD

KLSE (MYR): OBHB (0327)

You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!

Last Price

0.225

Today's Change

0.00 (0.00%)

Day's Change

0.22 - 0.225

Trading Volume

3,363,900

Financial
Market Cap

Market Cap

88 Million

NOSH

392 Million

Latest Quarter

Latest Quarter

31-Aug-2024 [#1]

Announcement Date

23-Oct-2024

Next Quarter

30-Nov-2024

Est. Ann. Date

23-Jan-2025

Est. Ann. Due Date

29-Jan-2025

QoQ | YoY

0.00% | 0.00%

T4Q Result

Revenue | NP to SH

|

RPS | P/RPS

 Cent | 0.00

EPS | P/E | EY

 Cent | 0.00 | 0.00%

DPS | DY | Payout %

 Cent | 0.00% |

NAPS | P/NAPS

| 0.00

QoQ | YoY

|

NP Margin | ROE

|

F.Y. | Ann. Date

|

Latest Audited Result

Latest Audited Result

Announcement Date

Next Audited Result

Est. Ann. Date

Est. Ann. Due Date

Annual (Unaudited)

Revenue | NP to SH

|

RPS | P/RPS

 Cent | 0.00

EPS | P/E | EY

 Cent | 0.00 | 0.00%

DPS | DY | Payout %

 Cent | 0.00% |

NAPS | P/NAPS

| 0.00

YoY

NP Margin | ROE

|

F.Y. | Ann. Date

|

Annualized Result

Revenue | NP to SH

48,088.000 | 5,768.000

RPS | P/RPS

12.28 Cent | 1.83

EPS | P/E | EY

1.47 Cent | 15.28 | 6.55%

DPS | DY | Payout %

-

NAPS | P/NAPS

-

QoQ | YoY

null% | null%

NP Margin | ROE

11.99% | 89.71%

F.Y. | Ann. Date

31-Aug-2024 | 23-Oct-2024

Business Process

Trailing 4 Quarters Trailing 8 Quarters
Available Quarters 4 Quarters 8 Quarters
Continuous Quarters Of Revenue Growth 1 / 2 50.00% 1 / 2 50.00%
Total Positive Profit Years 1 / 2 50.00% 1 / 2 50.00%
Continuous Quarters Of Positive Profit 1 / 2 50.00% 1 / 2 50.00%
Continuous Quarters Of Profit Growth 1 / 2 50.00% 1 / 2 50.00%
Continuous Quarters Of Adjusted EPS Growth 1 / 2 50.00% 1 / 2 50.00%
Total Dividend Years 0 / 2 0.00% 0 / 2 0.00%
Continuous Quarters Of Dividend 0 / 2 0.00% 0 / 2 0.00%
Continuous Quarters Of Dividend Growth 0 / 2 0.00% 0 / 2 0.00%
Continuous Quarters Of Adjusted Dps Growth 0 / 2 0.00% 0 / 2 0.00%
Average ROE 11.22% 11.22%
Average Net Profit Margin 6.00% 6.00%

Last 5 Financial Years Last 10 Financial Years
Available Years 5 Years 10 Years
Continuous Quarters Of Revenue Growth 0 / 0 0.00% 0 / 0 0.00%
Total Positive Profit Years 0 / 0 0.00% 0 / 0 0.00%
Continuous Quarters Of Positive Profit 0 / 0 0.00% 0 / 0 0.00%
Continuous Quarters Of Profit Growth 0 / 0 0.00% 0 / 0 0.00%
Continuous Quarters Of Adjusted EPS Growth 0 / 0 0.00% 0 / 0 0.00%
Total Dividend Years 0 / 0 0.00% 0 / 0 0.00%
Continuous Quarters Of Dividend 0 / 0 0.00% 0 / 0 0.00%
Continuous Quarters Of Dividend Growth 0 / 0 0.00% 0 / 0 0.00%
Continuous Quarters Of Adjusted Dps Growth 0 / 0 0.00% 0 / 0 0.00%
Average ROE 0.00% 0.00%
Average Net Profit Margin 0.00% 0.00%
Key Result

T4Q Annualized Annual (Unaudited) Last 10 FY Average Last 5 FY Average
Revenue 48,088 0 0
NP to SH 5,768 0 0
Dividend 0 0 0
Adjusted EPS 1.47 0.00 0.00
Adjusted DPS 0.00 0.00 0.00

NP to SH = Net Profit Attributable to Shareholder, EPS = Earning Per Share, DPS = Dividend Per Share

All figures in '000 unless specified.

EPS & DPS's figures in Cent.

Growth

LQ QoQ LQ YoY CQ YoY LQ vs Average of T4Q LQ vs Average of T8Q
Revenue 0.00% 0.00% 0.00% 100.00% 100.00%
NP to Owner 0.00% 0.00% 0.00% 100.00% 100.00%
Dividend 0.00% 0.00% 0.00% 0.00% 0.00%
Adjusted EPS 0.00% 0.00% 0.00% 100.00% 100.00%
Adjusted DPS 0.00% 0.00% 0.00% 0.00% 0.00%

LQ = Latest Quarter, CQ = Cumulative Quarter, T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, QoQ = Quarter on Quarter, YoY = Year on Year

T4Q vs LFY T4Q vs AL5FY T4Q vs AL10FY AQR vs LFY AQR vs AL5FY AQR vs AL10FY LFY YoY LFY vs AL5FY LFY vs AL10FY
Revenue 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NP to Owner 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Dividend 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Adjusted EPS 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Adjusted DPS 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, AL5FY = Average of Last 5 Financial Years, AL10FY = Average of Last 10 Financial Years, LFY = Latest Financial Year AQR = Annualized Quarter Result, YoY = Year on Year

Discussions
Be the first to like this. Showing 38 of 38 comments

DreamKaiser

Wow. Another interesting looking one for the Kaiser to get the ball🏀 rolling. Cool😎.

1 month ago

DreamKaiser

Supplement maker OB Holdings to raise RM28.8m from ACE Market IPO
Mior Arif & Luqman Amin
theedgemalaysia.com
27 Sep 2024, 03:09 pm

https://theedgemalaysia.com/node/728238

1 month ago

HugoUPUPUP

@dreamkaiser
This stock will fly?

1 month ago

DreamKaiser

Umm, well, I wish I could tell ya for absolute certain, bro. If only I could find a working crystal ball at BTS, LaLaPort or somewhere in TRX, ha ha ha.

3 weeks ago

DreamKaiser

Anyway ...

OB Holdings’ 19.58 mil IPO shares for public oversubscribed by 109 times
John Lai/theedgemalaysia.com
18 Oct 2024, 06:17 pm

https://theedgemalaysia.com/node/730732

3 weeks ago

DreamKaiser

Oh well, just going by the oversubscription figure of 109 times, maybe it could, huh.

But don't hold me to account if it does not, LOL.

3 weeks ago

DickyMe

Yah gah? Sumatec amacam? Sudah kaya atau koyak?
🤣🤣

3 weeks ago

EatCoconutCanWin

Dispute pulak. I get 10lots

2 weeks ago

sammyramon

KOYAKKKKKKK

2 weeks ago

mf

0.24

2 weeks ago

EatCoconutCanWin

ceo ini maciam baru goreng kuat, illegal punya kaya

2 weeks ago

EatCoconutCanWin

labubu

2 weeks ago

OKU_2020

Post removed.Why?

2 weeks ago

Apple2353

where got vroom... slowly dying like Sorento..

2 weeks ago

Tripaka

Nowadays ipo glut plus unfavorable market conditions not easy to get free money without working and worrying.

2 weeks ago

GotNot

thus counter could rebounce or not?

2 weeks ago

DreamKaiser

OB Holdings edges higher on ACE Market debut after RM29 mil IPO
Izzul Ikram & Yu Jien Lim theedgemalaysia.com
29 Oct 2024, 09:24 am

https://theedgemalaysia.com/node/731956

2 weeks ago

DreamKaiser

Aah, no vroom gah, ha ha ha.

Misti mau tggu skt lor, ki ki ki.

2 weeks ago

diuleiloumei

Tarak ONG, got disputes b4 listing, price can't jump

2 weeks ago

EatCoconutCanWin

this company bad reputation?

2 weeks ago

BursaKakis

OBHB is in fortified food and beverages (F&B) and dietary supplements to third party brand owners and Orgabio is in beverages premix manufacturer. OBHB @ 0.25 is trading at forward PE 17 & Orgabio @ 0.385 is trading at forward PE 23.

2 weeks ago

EatCoconutCanWin

Obhb bukan bikin food la. Diapa buat alat untuk menyenangkan pembikinan makanan

2 weeks ago

BursaKakis

OB Holdings to more than double production capacity with new factory
https://theedgemalaysia.com/node/731961

2 weeks ago

BursaKakis

OBHB are in compliance with various International & Malaysian recognized standards incl. U.S FDA ( Food & Drug Administration), U.S. HACCP (Hazard Analysis Critical Control Points System) , Australia NASAA Certified Organic, ISO 9001:2015 International Quality Management System, MeSTI from Kementerian Kesihatan, NPRA Malaysia from National Pharmaceutical Regulatory Agency, GMP Certified Good Manufacturing Practises, Halal Cert, etc. Kindly refer to the co presentation slides posted in BursaKakis Telegram Channel.

2 weeks ago

OKU_2020

Post removed.Why?

2 weeks ago

EatCoconutCanWin

sial punya director ..tiok dispute

2 weeks ago

AmberAsset

Hahaha welcome to bursa

2 weeks ago

NRahmat

Fly! TP RM 0.290

1 week ago

BursaKakis

We ascribe a fair value of RM0.385 (an upside of 60.4% against IPO price of RM0.24)
for OBHB. Our valuation is derived by pegging a P/E of 18x to the mid-FY26f EPS of
2.13 sen. We believe the P/E of 18x is fair, given that the average P/E of the closest
peers (Fig #7) stands at 17.6x - Mcca Securities

1 week ago

Michael Kwok

Bursa kakis not exactly the figures.1+1 not always 2 in bad times.
4/11/24 2.55pm

1 week ago

NRahmat

Break R1.. next target R2 RM 0.290

1 week ago

NRahmat

Hit 0.275

1 week ago

ktrader

Tomolo hit 0.29 meh

1 week ago

billionn

RUN FOR YOUR LIFE!!!

1 week ago

AlexChiaWS

They are so confident on that dispute issue with Nature One Dairy.

That Obhb issue statement:
“However, Orient Biotech has put NOD on notice that it will hold NOD liable and seek full indemnification from NOD from and against all losses, damages, claims, expenses, proceedings, suits, legal costs (on a solicitor and client basis) that Orient Biotech may suffer as a consequence of the Dispute Notice, including but not limited to arising from compliance with NOD’s cease and desist demand, if NOD’s claims are found to be unsubstantiated or without merit,”

Obhb told the media that:
“Based on the presented facts, there are differences between formulations and ingredients of the Relevant Product and NOD’s milk powder products. The common ingredients are generic and found in other products with similar purposes and benefits.

1 week ago

billionn

anything below 0.275 better sell. RUN FOR YOUR LIFE TOMMORROW

1 week ago

Post a Comment